Integral Health Asset Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $1.98 Million - $3.5 Million	-50,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$58.09 - $82.51 $2.9 Million - $4.13 Million	50,000 New	50,000 $3.32 Million
Q1 2021 May 10, 2021	SELL	$61.35 - $90.47 $3.07 Million - $4.52 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $2.19 Million - $4.27 Million	50,000 New	50,000 $3.84 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.